Labcorp Holdings
At a glance
Labcorp Holdings reported 2025 revenue of $13.95B, up 7.2% from $13.01B in 2024. Over 4 years since 2021 ($13.14B), that is growth of about 1.5% a year. Operating margin was 9.9%, down from 23.2% in 2021. 2025 was the highest revenue year in this period.
In the last 12 months 10 insiders reported 0 open-market purchases and 20 sales ($13.7M). 14 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $2.4M by President & CEO Adam H Schechter on Mar 5, 2026.
Labcorp Holdings filed 26 current reports (Form 8-K) in the last 12 months, most often for regulation fd disclosure (14), officer or director change (5), results of operations (4) and material agreement (2). The latest officer or director change was reported on Aug 14, 2026. It reported a material agreement or a completed acquisition or disposal 2 times.
2 of the 20 investors tracked here held Labcorp Holdings at the last quarter end, worth $12.9M combined. It is the largest weight for National Pension Service (Korea) (0% of its portfolio), followed by Bridgewater Associates (0%). Reduced: National Pension Service (Korea) and Bridgewater Associates.
Annual results
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net income | $2.38B | $1.28B | $418M | $746M | $877M |
| Diluted EPS | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 |
| Dividend per share | - | $2.16 | $2.88 | $2.88 | $2.88 |
Fiscal year ends Dec 31
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined